Drug pipeline 3Q21-mixed news for genetic therapies

Drug pipeline 3Q21-mixed news for genetic therapies

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2021-11, Vol.39 (11), p.1326-1328
1. Verfasser: DeFrancesco, Laura
Format: Artikel
Sprache:eng
Schlagworte:
Drug approval
Gene therapy
Laws, regulations and rules
Monoclonal antibodies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1328
container_issue 11
container_start_page 1326
container_title Nature biotechnology
container_volume 39
creator DeFrancesco, Laura
description
doi_str_mv 10.1038/s41587-021-01119-8
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2596011513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A682130640</galeid><sourcerecordid>A682130640</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-5bec4f628ae8c2aa7a774fd4cca699f079ac5be711dd3412f601b47880794f963</originalsourceid><addsrcrecordid>eNqNkltrFTEQx4Motla_gA-y4IuCWzObbDZ5LPVWKBSvryEnO9mm7M1kF-u3d05PvRzxQQLJkPn9J8Pkz9hj4MfAhX6ZJdS6KXkFJQcAU-o77BBqqUpQRt2lmG_TUKsD9iDnK865kkrdZwdCNrWESh0y8SqtXTHHGfs4YiHeU7EhXmNbjPgtF2FKRYcjLtEXyyUmN0fMD9m94PqMj27PI_b5zetPp-_K84u3Z6cn56WXRi9lvUEvg6q0Q-0r5xrXNDK00nunjAm8Mc4T0wC0raBuguKwkY3WlJHBKHHEnu3qzmn6umJe7BCzx753I05rtlVtSAI1CEKf_oVeTWsaqbsbCuhlU_2mOtejjWOYluT8tqg9UboCQfPhRB3_g6LV4hD9NGKIdL8neL4nIGbB66Vza8727OOH_2cvvuyzL_5gN2umH8q05dhdLnkn2cOrHe7TlHPCYOcUB5e-W-B2axi7M4wlw9gbw1hNoie3g1s3A7a_JD8dIn4AFYG08A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2596177492</pqid></control><display><type>article</type><title>Drug pipeline 3Q21-mixed news for genetic therapies</title><source>Nature</source><source>SpringerLink_现刊</source><creator>DeFrancesco, Laura</creator><creatorcontrib>DeFrancesco, Laura</creatorcontrib><identifier>ISSN: 1087-0156</identifier><identifier>EISSN: 1546-1696</identifier><identifier>DOI: 10.1038/s41587-021-01119-8</identifier><identifier>PMID: 34754126</identifier><language>eng</language><publisher>United States: Nature Publishing Group</publisher><subject>Drug approval ; Gene therapy ; Laws, regulations and rules ; Monoclonal antibodies</subject><ispartof>Nature biotechnology, 2021-11, Vol.39 (11), p.1326-1328</ispartof><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Nov 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34754126$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DeFrancesco, Laura</creatorcontrib><title>Drug pipeline 3Q21-mixed news for genetic therapies</title><title>Nature biotechnology</title><addtitle>Nat Biotechnol</addtitle><subject>Drug approval</subject><subject>Gene therapy</subject><subject>Laws, regulations and rules</subject><subject>Monoclonal antibodies</subject><issn>1087-0156</issn><issn>1546-1696</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>N95</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkltrFTEQx4Motla_gA-y4IuCWzObbDZ5LPVWKBSvryEnO9mm7M1kF-u3d05PvRzxQQLJkPn9J8Pkz9hj4MfAhX6ZJdS6KXkFJQcAU-o77BBqqUpQRt2lmG_TUKsD9iDnK865kkrdZwdCNrWESh0y8SqtXTHHGfs4YiHeU7EhXmNbjPgtF2FKRYcjLtEXyyUmN0fMD9m94PqMj27PI_b5zetPp-_K84u3Z6cn56WXRi9lvUEvg6q0Q-0r5xrXNDK00nunjAm8Mc4T0wC0raBuguKwkY3WlJHBKHHEnu3qzmn6umJe7BCzx753I05rtlVtSAI1CEKf_oVeTWsaqbsbCuhlU_2mOtejjWOYluT8tqg9UboCQfPhRB3_g6LV4hD9NGKIdL8neL4nIGbB66Vza8727OOH_2cvvuyzL_5gN2umH8q05dhdLnkn2cOrHe7TlHPCYOcUB5e-W-B2axi7M4wlw9gbw1hNoie3g1s3A7a_JD8dIn4AFYG08A</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>DeFrancesco, Laura</creator><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>N95</scope><scope>XI7</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20211101</creationdate><title>Drug pipeline 3Q21-mixed news for genetic therapies</title><author>DeFrancesco, Laura</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-5bec4f628ae8c2aa7a774fd4cca699f079ac5be711dd3412f601b47880794f963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Drug approval</topic><topic>Gene therapy</topic><topic>Laws, regulations and rules</topic><topic>Monoclonal antibodies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DeFrancesco, Laura</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale_Business Insights: Global</collection><collection>Business Insights: Essentials</collection><collection>Gale in Context : Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DeFrancesco, Laura</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug pipeline 3Q21-mixed news for genetic therapies</atitle><jtitle>Nature biotechnology</jtitle><addtitle>Nat Biotechnol</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>39</volume><issue>11</issue><spage>1326</spage><epage>1328</epage><pages>1326-1328</pages><issn>1087-0156</issn><eissn>1546-1696</eissn><cop>United States</cop><pub>Nature Publishing Group</pub><pmid>34754126</pmid><doi>10.1038/s41587-021-01119-8</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1087-0156
ispartof Nature biotechnology, 2021-11, Vol.39 (11), p.1326-1328
issn 1087-0156
1546-1696
language eng
recordid cdi_proquest_miscellaneous_2596011513
source Nature; SpringerLink_现刊
subjects Drug approval
Gene therapy
Laws, regulations and rules
Monoclonal antibodies
title Drug pipeline 3Q21-mixed news for genetic therapies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A20%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20pipeline%203Q21-mixed%20news%20for%20genetic%20therapies&rft.jtitle=Nature%20biotechnology&rft.au=DeFrancesco,%20Laura&rft.date=2021-11-01&rft.volume=39&rft.issue=11&rft.spage=1326&rft.epage=1328&rft.pages=1326-1328&rft.issn=1087-0156&rft.eissn=1546-1696&rft_id=info:doi/10.1038/s41587-021-01119-8&rft_dat=%3Cgale_proqu%3EA682130640%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2596177492&rft_id=info:pmid/34754126&rft_galeid=A682130640&rfr_iscdi=true